FDA warns mouthwash makers on false claims

By Parija Kavilanz, senior writer


NEW YORK (CNNMoney.com) -- The Food and Drug Administration on Tuesday warned Johnson & Johnson, CVS and Walgreen to stop making "unproven" claims that their mouthwash products are effective in removing plaque or preventing gum disease.

In a warning letter sent to each company, regulators specifically targeted Johnson & Johnson's "Listerine Total Care Anticavity Mouthwash", CVS (CVS, Fortune 500)'s "CVS Complete Care Anticavity Mouthwash" and Walgreen's (WAG, Fortune 500) "Walgreen Mouth Rinse Full Action."

"These mouth rinse products contain the active ingredient sodium fluoride. The FDA has determined that sodium fluoride is effective in preventing cavities but has not found this ingredient to be effective in removing plaque or preventing gum disease," the agency said in a statement.

"It is important for the FDA to take appropriate enforcement action when companies make false or unproven product claims to ensure that consumers are not misinformed or misled," said Deborah Author, director of the Office of Compliance with the FDA.

According to federal law, a company cannot claim its product is effective in treating a disease unless those claims have been reviewed and approved by the FDA.

The agency said it is unaware of any injuries or adverse health effects related to the use of the mouth rinse products.

The FDA has given all three companies 15 days to take "appropriate action" to correct the violations or else face product seizure or other civil or criminal penalties.

CVS spokesman Mike DeAngelis said the company is reviewing the FDA's letter and will reply within the required 15 working days of receipt.

"Our policy is to fully comply with all FDA labeling requirements," said DeAngelis.

Johnson & Johnson said its Johnson & Johnson Healthcare Products Division of McNeil PPC "is in receipt of the letter from the U.S. Food and Drug Administration and the company will respond to the agency in an appropriate and timely manner."

More heat for Johnson & Johnson

The warning adds to a growing litany of problems for Johnson & Johnson (JNJ, Fortune 500).

On Thursday, the company faces a second Congressional hearing into a string of recalls of its non-prescription drugs such as Tylenol, Benadryl and Motrin. Those drugs are made by Johnson & Johnson's McNeil Consumer Healthcare division.

McNeil has issued nine recalls of those drugs over the past year. In April, McNeil recalled 135 million bottles of children's and infant's Motrin, Tylenol, Benadryl and Zyrtec drugs for quality issues. It was the largest recall of children's non-prescription drugs.

The Committee on Oversight and Government Reform, which has been investigating McNeil, held its first hearing about the recalls in May.

During the hearing, lawmakers disclosed that McNeil also tried to conduct a secret recall of more than 88,000 Motrin tablets in June 2009 for a possible defect in the drugs.

Johnson & Johnson CEO William Weldon did not testify at the May hearing. Weldon was again invited by the committee to testify at Thursday's hearing. To top of page

Frontline troops push for solar energy
The U.S. Marines are testing renewable energy technologies like solar to reduce costs and casualties associated with fossil fuels. Play
25 Best Places to find rich singles
Looking for Mr. or Ms. Moneybags? Hunt down the perfect mate in these wealthy cities, which are brimming with unattached professionals. More
Fun festivals: Twins to mustard to pirates!
You'll see double in Twinsburg, Ohio, and Ketchup lovers should beware in Middleton, WI. Here's some of the best and strangest town festivals. Play
Index Last Change % Change
Dow 17,888.99 84.19 0.47%
Nasdaq 4,765.20 -0.18 -0.00%
S&P 500 2,070.10 -0.55 -0.03%
Treasuries 2.18 0.00 0.23%
Data as of 12:06pm ET
Company Price Change % Change
Gilead Sciences Inc 93.34 -15.11 -13.93%
Facebook Inc 81.57 1.69 2.12%
Bank of America Corp... 17.63 0.01 0.05%
Apple Inc 113.08 1.30 1.16%
General Electric Co 25.64 0.02 0.08%
Data as of 11:51am ET

Sections

Private equity titan CEO David Rubenstein drops some rhymes in a holiday message to investors. More

UPS and FedEx employ teams of meteorologists whose nightmare is a "big snow or ice storm at one of our hubs" during the peak holiday shipping season. More

BitTorrent says it's the perfect candidate for Sony to release "The Interview." It's also the network that was used to share the stolen Sony documents. More

Unilever sued Hampton Creek over its egg-free mayonnaise spread Just Mayo. But the company behind Best Foods and Hellman's mayonnaise has now dropped the lawsuit. More

Retired union workers could see their pensions cut under a controversial new law, but many say they're not sure how they'll make ends meet if big cuts go through. More

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.